Emerimicin III
| Internal ID | 4b146f75-4d68-44a7-ac72-feba35b62561 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides |
| IUPAC Name | (2R)-2-[[(2S,4R)-1-[2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[2-[[2-[[2-[[(2S)-2-acetamido-3-phenylpropanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]-4-hydroxypyrrolidine-2-carbonyl]amino]-N-[(2S)-1-[(2R,4S)-4-hydroxy-2-[[(2S)-1-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxobutan-2-yl]pentanediamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C76H118N16O19/c1-19-76(18,70(111)92-39-49(96)35-53(92)62(103)79-43(6)58(99)81-47(40-93)33-45-26-22-20-23-27-45)87-59(100)50(30-31-55(77)97)83-63(104)54-36-48(95)38-91(54)69(110)75(16,17)90-67(108)73(12,13)85-60(101)51(32-41(2)3)82-56(98)37-78-64(105)57(42(4)5)84-65(106)71(8,9)88-68(109)74(14,15)89-66(107)72(10,11)86-61(102)52(80-44(7)94)34-46-28-24-21-25-29-46/h20-29,41-43,47-54,57,93,95-96H,19,30-40H2,1-18H3,(H2,77,97)(H,78,105)(H,79,103)(H,80,94)(H,81,99)(H,82,98)(H,83,104)(H,84,106)(H,85,101)(H,86,102)(H,87,100)(H,88,109)(H,89,107)(H,90,108)/t43-,47-,48+,49-,50+,51-,52-,53+,54-,57+,76-/m0/s1 |
| InChI Key | XGVDUVYDSSWAQF-JPVWLDROSA-N |
| Popularity | 3 references in papers |
| Molecular Formula | C76H118N16O19 |
| Molecular Weight | 1559.80 g/mol |
| Exact Mass | 1558.87591560 g/mol |
| Topological Polar Surface Area (TPSA) | 523.00 Ų |
| XlogP | 0.00 |
| Atomic LogP (AlogP) | -2.82 |
| H-Bond Acceptor | 19 |
| H-Bond Donor | 17 |
| Rotatable Bonds | 39 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8802 | 88.02% |
| Caco-2 | - | 0.8623 | 86.23% |
| Blood Brain Barrier | - | 0.8500 | 85.00% |
| Human oral bioavailability | - | 0.6571 | 65.71% |
| Subcellular localzation | Lysosomes | 0.5510 | 55.10% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8375 | 83.75% |
| OATP1B3 inhibitior | + | 0.9310 | 93.10% |
| MATE1 inhibitior | - | 0.9012 | 90.12% |
| OCT2 inhibitior | - | 0.8250 | 82.50% |
| BSEP inhibitior | + | 0.9772 | 97.72% |
| P-glycoprotein inhibitior | + | 0.7421 | 74.21% |
| P-glycoprotein substrate | + | 0.8817 | 88.17% |
| CYP3A4 substrate | + | 0.7481 | 74.81% |
| CYP2C9 substrate | - | 0.7958 | 79.58% |
| CYP2D6 substrate | - | 0.8176 | 81.76% |
| CYP3A4 inhibition | + | 0.8429 | 84.29% |
| CYP2C9 inhibition | - | 0.8072 | 80.72% |
| CYP2C19 inhibition | - | 0.7374 | 73.74% |
| CYP2D6 inhibition | - | 0.7827 | 78.27% |
| CYP1A2 inhibition | - | 0.9575 | 95.75% |
| CYP2C8 inhibition | + | 0.6958 | 69.58% |
| CYP inhibitory promiscuity | - | 0.9258 | 92.58% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.7100 | 71.00% |
| Carcinogenicity (trinary) | Non-required | 0.6147 | 61.47% |
| Eye corrosion | - | 0.9906 | 99.06% |
| Eye irritation | - | 0.8955 | 89.55% |
| Skin irritation | - | 0.7960 | 79.60% |
| Skin corrosion | - | 0.9172 | 91.72% |
| Ames mutagenesis | - | 0.6500 | 65.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7201 | 72.01% |
| Micronuclear | + | 0.7800 | 78.00% |
| Hepatotoxicity | + | 0.5032 | 50.32% |
| skin sensitisation | - | 0.8903 | 89.03% |
| Respiratory toxicity | + | 0.8556 | 85.56% |
| Reproductive toxicity | + | 0.9444 | 94.44% |
| Mitochondrial toxicity | + | 0.9000 | 90.00% |
| Nephrotoxicity | - | 0.8585 | 85.85% |
| Acute Oral Toxicity (c) | III | 0.6509 | 65.09% |
| Estrogen receptor binding | - | 0.5423 | 54.23% |
| Androgen receptor binding | + | 0.7658 | 76.58% |
| Thyroid receptor binding | + | 0.7696 | 76.96% |
| Glucocorticoid receptor binding | + | 0.8454 | 84.54% |
| Aromatase binding | + | 0.8036 | 80.36% |
| PPAR gamma | + | 0.7855 | 78.55% |
| Honey bee toxicity | - | 0.7123 | 71.23% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | - | 0.5800 | 58.00% |
| Fish aquatic toxicity | + | 0.8535 | 85.35% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.96% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.78% | 96.61% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 99.48% | 90.17% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.73% | 96.09% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 98.11% | 94.45% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 97.38% | 97.23% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.21% | 98.33% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 97.17% | 97.14% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.63% | 91.11% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 94.71% | 82.69% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 93.95% | 97.09% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 93.57% | 100.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 93.44% | 91.19% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 93.12% | 93.56% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 92.40% | 100.00% |
| CHEMBL236 | P41143 | Delta opioid receptor | 91.92% | 99.35% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 91.74% | 96.03% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 91.65% | 89.63% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 91.21% | 95.38% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 91.16% | 93.00% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 90.80% | 98.94% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 90.66% | 96.67% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 90.38% | 89.33% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 89.94% | 95.50% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 89.65% | 97.64% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 89.43% | 97.25% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 89.04% | 88.42% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 88.98% | 97.21% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 88.43% | 100.00% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 88.32% | 99.17% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 87.71% | 100.00% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 87.27% | 96.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 86.46% | 96.47% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 86.43% | 95.56% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 86.28% | 92.80% |
| CHEMBL3891 | P07384 | Calpain 1 | 86.11% | 93.04% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 85.85% | 90.71% |
| CHEMBL5028 | O14672 | ADAM10 | 85.23% | 97.50% |
| CHEMBL2535 | P11166 | Glucose transporter | 84.62% | 98.75% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 84.51% | 97.50% |
| CHEMBL1821 | P08173 | Muscarinic acetylcholine receptor M4 | 84.20% | 94.08% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 83.86% | 96.90% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 83.06% | 95.00% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 82.88% | 86.67% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 82.68% | 95.83% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 82.26% | 95.89% |
| CHEMBL216 | P11229 | Muscarinic acetylcholine receptor M1 | 82.03% | 94.23% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 81.77% | 93.33% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 81.75% | 96.37% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 81.46% | 81.29% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 81.00% | 94.45% |
| CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 80.69% | 94.62% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 80.36% | 89.50% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 80.16% | 85.11% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139589343 |
| LOTUS | LTS0007108 |
| wikiData | Q105327835 |